Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2008
02/05/2008US7326532 Detection of rpoB sequences of mycobacterium tuberculosis
02/05/2008US7326531 Proteases from gram-positive organisms
02/05/2008US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis
02/05/2008US7326417 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
02/05/2008US7326413 Antibodies against the PRO1434 polypeptide
02/05/2008CA2223821C Magnetic particles with a glass surface and their use
01/2008
01/31/2008WO2008014054A2 Bmp-7 variant compositions, methods and uses
01/31/2008WO2008013910A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
01/31/2008WO2008013590A2 Implementation of a mitochondrial mutator
01/31/2008WO2008013552A2 Fully human hybridoma fusion partner cell lines
01/31/2008WO2007103485A3 Small rna purification
01/31/2008WO2007047256A3 Svv-based animal vaccines and uses thereof
01/31/2008WO2006113909A3 Humanized anti-cd70 binding agents and uses thereof
01/31/2008WO2006096951A3 Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family
01/31/2008US20080028490 Oil enhancing genes; diacylglycerol acyltransferase, phosphatidic acid phosphatase, and leucoanthocyanidin dioxygenase; transgenic seeds, cells, plants; feeds
01/31/2008US20080028489 Guard cell-specific tool for molecular manipulation of drought avoidance/water loss in plants
01/31/2008US20080028486 Aluminium Tolerant Barley
01/31/2008US20080028482 Corn Plant Mon88017 and Compositions and Methods for Detection Thereof
01/31/2008US20080027217 Method to Obtain Purified Human Genomic Nucleic Acid
01/31/2008US20080027216 siRNA targeting sodium channel, voltage-gated, type X, alpha (SCN10A)
01/31/2008US20080027215 siRNA targeting vascular endothelial growth factor (VEGF)
01/31/2008US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes
01/31/2008US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders
01/31/2008US20080027015 Methods and Materials for Modulating Enac-Beta
01/31/2008US20080027005 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
01/31/2008US20080027004 Phosphorylated COP1 molecules and uses thereof
01/31/2008US20080027002 Compositions and methods for targeting cancer-specific transcription complexes
01/31/2008US20080026982 Mutant APOBEC3G molecules for inhibiting replication of HIV
01/31/2008US20080026976 Highly productive alpha-amylases
01/31/2008US20080026953 Assay for Detecting and Identifying Micro-Organisms
01/31/2008US20080026950 Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
01/31/2008US20080026466 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life
01/31/2008US20080026440 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
01/31/2008US20080026439 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026438 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026437 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026436 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026435 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026434 Pufa polyketide synthase systems and uses thereof
01/31/2008US20080026432 Novel L-Threonine Importer From Corynebacterium And A Preparation Method Of A Strain Producing L-Threonine
01/31/2008US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF
01/31/2008US20080026426 Anti-infective therapy
01/31/2008US20080026424 having replacements in the amino acid sequence and where the subdomain of the polypeptide is modified so that the rate stability is maintained relative to the wild-type polypeptide
01/31/2008US20080026423 DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods
01/31/2008US20080026421 Transgenic cells comprising peroxisomal membrane polypeptide (PMP) for transport of intracellular proteins to ouside of cell
01/31/2008US20080026398 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
01/31/2008US20080026396 Method and nucleic acids for the analysis of astrocytomas
01/31/2008US20080026393 Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby
01/31/2008US20080026389 Screen for anti-infective compounds
01/31/2008US20080026387 Methods and compositions for detection of a target nucleic acid sequence utilizing a probe with a 3' flap
01/31/2008US20080026385 Oligonucleotides For Cancer Diagnosis
01/31/2008US20080026384 Methods and compositions for the detection of bovine pregnancy
01/31/2008US20080026381 Sequencing nucleic acid molecules; promote accurate base-over-base incorporation in sequencing-by-synthesis reactions, resulting in greater read lengths
01/31/2008US20080026379 Nucleotide analogs
01/31/2008US20080026376 KEX2 cleavage regions of recombinant fusion proteins
01/31/2008US20080026375 Compositions and Methods for Isolation of Biological Molecules
01/31/2008US20080026371 Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject Outcome
01/31/2008US20080026370 Method For Geno-And Pathotyping Pseudomonas Aeruginosa
01/31/2008US20080026363 Acetyl coa carboxylase 2 sequences and methods
01/31/2008US20080026011 Immunostimulatory nucleic acid molecules
01/31/2008US20080025982 Uses of Sperm Membrane Protein Obf
01/31/2008US20080025974 Toll-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation and viral infection
01/31/2008US20080025968 Methods and Agents for Immune Modulation and Methods for Identifying Immune Modulators
01/31/2008US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain
01/31/2008US20080025944 Combination Therapy for Immunostimulation
01/31/2008CA2659194A1 Methods for identifying, diagnosing, and predicting survival of lymphomas
01/31/2008CA2658563A1 Crohn disease susceptibility gene
01/31/2008CA2619983A1 Fully human hybridoma fusion partner cell lines
01/30/2008EP1882748A2 A population of nucleic acids including a subpopulation of LNA oligomers
01/30/2008EP1882047A2 Compositions, methods and kits for real-time nucleic acid analysis in live cells
01/30/2008EP1694855A4 Oligonucleotides and methods for detection of west nile virus
01/30/2008EP1687450A4 Real-time detection of nucleic acids and proteins
01/30/2008EP1163254B1 Trpm-2 antisense therapy
01/30/2008EP0737249B1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
01/30/2008CN101115769A Interferon-alpha polypeptides and conjugates
01/30/2008CN101115494A Method of modulating vascularization
01/30/2008CN101113447A Antineoplastic small molecule interfering RNA and its anti-tumor use
01/30/2008CN101113446A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113445A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113444A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113443A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113442A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113441A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113440A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113439A siRNA for suppressing VEGF expression and breeding of tumour and leukemia cell and application thereof
01/30/2008CN101113438A Antisense STAT3 oligonucleotide and uses thereof
01/30/2008CN101113160A Nucleic acid-based compounds and methods of use thereof
01/30/2008CN101113159A Structure and usage of antisense oligonucleotide for preventing and treating lung carcinoma cell invasion transition
01/30/2008CN101113158A siRNA disturbing RdRp gene function of SARS virus
01/30/2008CN100365123C SiRNA sequence directing towards influenza B virus membrane protein gene and its application
01/30/2008CN100365122C SiRNA sequence directing towards influenza B virus polymerase gene and its application
01/30/2008CN100365121C SiRNA sequence directing towards influenza B virus nucleocapsid gene and its application
01/30/2008CN100365009C Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use
01/30/2008CN100364438C Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
01/29/2008US7323622 Expression vector comprising nucleotide sequences coding methyltransferase regulatory sequence for use as tool in controlling transcription of heterologous genes associated with conferring insect resistance; disease resistant plants
01/29/2008US7323619 Generation of genetically engineered animals; for use as models in the evaluation of disease
01/29/2008US7323571 Heterodimeric dye composition
01/29/2008US7323560 Plastidic phosphoglucomutase genes
01/29/2008US7323559 Genes encoding genetic stability, gene expression and folding proteins
01/29/2008US7323558 Nucleotide sequences coding polypeptides; DNAs encoding such dendritic cell transmembrane serine proteases, and pharmaceutical and/or diagnostic compositions made therefrom, are disclosed; serine protease activity